April 2025
1. PRICE MZ, Small GW
   Benefits and Risks of New Tests for Alzheimer's Disease.
   J Clin Psychiatry. 2025;86:25com15837.
   

   >> Share

   
   November 2024
2. JAIN R, Chepke C, Davis LL, McIntyre RS, et al
   Dysregulation of Noradrenergic Activity: Its Role in Conceptualizing and Treating Major Depressive Disorder, Schizophrenia, Agitation in Alzheimer's Disease, and Posttraumatic Stress Disorder.
   J Clin Psychiatry. 2024;85:plunaro2417ah.
   

   >> Share

   
   August 2023
3. ANDRADE C
   How to Use Percentiles to Better Understand Standardized Mean Difference (SMD) as a Measure of Effect Size.
   J Clin Psychiatry. 2023;84:23f15028.
   

   >> Share

   
   July 2023
4. ANDRADE C
   Cholinesterase Inhibitors for Delusions and Hallucinations in Alzheimer Disease and Parkinson Disease: Questionably Significant Benefits.
   J Clin Psychiatry. 2023;84:23f15009.
   

   >> Share

   
   March 2023
5. BURKE AD, Goldfarb D
   Diagnosing and Treating Alzheimer Disease During the Early Stage.
   J Clin Psychiatry. 2023;84:LI21019AH3C.
   

   >> Share

   
   
6. LENZE EJ, Reiersen AM, Zorumski CF, Santosh PJ, et al
   Beyond "Psychotropic": Repurposing Psychiatric Drugs for COVID-19, Alzheimer's Disease, and Cancer.
   J Clin Psychiatry. 2023;84:22r14494.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share